{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:02:56Z","timestamp":1793714576195,"version":"4.6.1"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Type 1 Diabetes Mellitus (T1DM) is a chronic autoimmune disease,\nwhich is characterized by an increased prevalence worldwide, which, in fact, tends to take extensive\ndimensions. The recent rapid development of science and technology has significantly contributed\nto the improvement of the management of type 1 diabetes mellitus, both in achieving the\nrequired euglycaemic regulation and reducing the psychological burden associated with the disease,\nconsequently improving the quality of life of the patients with type 1 diabetes mellitus.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A literature review from 2010, related to the contribution of the modern insulin analogues,\ncontinuous glucose monitoring and the insulin pump, was performed using Scopus, ScienceDirect\nand PubMed databases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Studies included in the review support a direct and indirect association of technological innovations\nwith the quality of life. The use of type 1 diabetes mellitus technology was negatively associated\nwith the frequency of the hypoglycaemias and the value of the glycosylated hemoglobin,\nwhile at the same time, the development and use of the related technology were highly associated\nwith an improvement in the quality of life.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Patients\u2019 quality of life is an indicator of the management of type 1 diabetes mellitus,\nand it is just as important as glycaemic regulation. Through this review, it was concluded that a better\nquality of life of T1DM patients was associated with the improvement of glycosylated hemoglobin\nand hypoglycemic episodes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399818666211103163208","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T06:18:12Z","timestamp":1636006692000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Technological Developments and Quality of Life in Type 1 Diabetes Mellitus\nPatients: A Review of the Modern Insulin Analogues, Continuous Glucose\nMonitoring and Insulin Pump Therapy"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-254X","authenticated-orcid":true,"given":"Emmanouil","family":"Benioudakis","sequence":"first","affiliation":[{"name":"Psychiatric Clinic of the General Hospital of Chania, Chania, Greece"},{"name":"School of Medicine, Aristotle University of\nThessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Karlafti","sequence":"additional","affiliation":[{"name":"Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Medical\nSchool, \u201cAHEPA\u201d Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6416-9740","authenticated-orcid":true,"given":"Argyroula","family":"Kalaitzaki","sequence":"additional","affiliation":[{"name":"Laboratory of Interdisciplinary\nApproaches to the Enhancement of Quality of Life, Social Work Department, Health Sciences Faculty, Hellenic\nMediterranean University, Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Kaiafa","sequence":"additional","affiliation":[{"name":"Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Medical\nSchool, \u201cAHEPA\u201d Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Savopoulos","sequence":"additional","affiliation":[{"name":"Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Medical\nSchool, \u201cAHEPA\u201d Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0236-8760","authenticated-orcid":true,"given":"Triantafyllos","family":"Didangelos","sequence":"additional","affiliation":[{"name":"Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Medical\nSchool, \u201cAHEPA\u201d Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2019","unstructured":"IDF Diabetes Atlas International Diabetes Federation2019","journal-title":"IDF Diabetes Atlas"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","year":"2020","unstructured":"2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2020. Diabetes Care American Diabetes Association2020,43(Suppl. 1),S14-S31","journal-title":"Diabetes Care"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2337\/diacare.13.4.427","volume":"13","year":"1990","unstructured":"Diabetes control and complications trial (DCCT): Update. Diabetes Care DCCT Research Group1990,13(4),427-433","journal-title":"Diabetes Care"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2337\/dc13-2148","volume":"37","author":"Gubitosi-Klug R.A.","year":"2014","unstructured":"Gubitosi-Klug R.A.; The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: Summary and future directions. Diabetes Care 2014,37(1),44-49","journal-title":"Diabetes Care"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.2337\/dc19-S007","volume":"42","year":"2019","unstructured":"7. Diabetes technology: Standards of medical care in diabetes-2019. Diabetes Care American Diabetes Association2019,42(Suppl. 1),S71-S80","journal-title":"Diabetes Care"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S833","DOI":"10.1016\/j.dsx.2017.07.003","volume":"11","author":"Nawaz M.S.","year":"2017","unstructured":"Nawaz M.S.; Shah K.U.; Khan T.M.; Rehman A.U.; Rashid H.U.; Mahmood S.; Khan S.; Farrukh M.J.; Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus. Diabetes Metab Syndr 2017,11(Suppl. 2),S833-S839","journal-title":"Diabetes Metab Syndr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.amjms.2019.07.003","volume":"358","author":"Mian Z.","year":"2019","unstructured":"Mian Z.; Hermayer K.L.; Jenkins A.; Continuous glucose monitoring: Review of an innovation in diabetes management. Am J Med Sci 2019,358(5),332-339","journal-title":"Am J Med Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.amjms.2019.08.008","volume":"358","author":"Sora N.D.","year":"2019","unstructured":"Sora N.D.; Shashpal F.; Bond E.A.; Jenkins A.J.; Insulin pumps: Review of technological advancement in diabetes management. Am J Med Sci 2019,358(5),326-331","journal-title":"Am J Med Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ecl.2019.10.006","volume":"49","author":"Kravarusic J.","year":"2020","unstructured":"Kravarusic J.; Aleppo G.; Diabetes technology use in adults with type 1 and type 2 diabetes. Endocrinol Metab Clin North Am 2020,49(1),37-55","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref=10","year":"2007","unstructured":"A Textbook Ogden J. Health Psychology2007","journal-title":"A Textbook"},{"key":"ref=11","year":"1998","unstructured":"Programme on mental health : WHOQOL user manual, 2012 revision. World Health Organization World Health OrganizationAvailable from: \n1998","journal-title":"World Health Organization"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1464-5491.2007.02346.x","volume":"25","year":"2008","unstructured":"Quality of life and treatment satisfaction in adults with type 1 diabetes: A comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med EQuality1 Study Group-Evaluation of QUALITY of Life and Costs in Diabetes Type 1, Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, Bruttomesso D, et al 2008,25,213-220","journal-title":"Diabet Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.diabet.2010.12.003","volume":"37","author":"Rys P.","year":"2011","unstructured":"Rys P.; Pankiewicz O.; \u0141ach K.; Kwaskowski A.; Skrzekowska-Baran I.; Malecki M.T.; Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: A systematic review. Diabetes Metab 2011,37(3),190-200","journal-title":"Diabetes Metab"},{"key":"ref=14","author":"Morrison V.","year":"2009","unstructured":"Morrison V.; Bennett P.;  An Introduction to Health Psychology 2009","journal-title":"An Introduction to Health Psychology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/bmj.325.7367.746","volume":"325","year":"2002","unstructured":"Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment For Normal Eating (DAFNE) randomised controlled trial. BMJ DAFNE Study Group2002,325(7367),746","journal-title":"BMJ"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2337\/dc16-1990","volume":"40","author":"Anderson B.J.","year":"2017","unstructured":"Anderson B.J.; Laffel L.M.; Domenger C.; Danne T.; Phillip M.; Mazza C.; Hanas R.; Waldron S.; Beck R.W.; Calvi-Gries F.; Mathieu C.; Factors associated with diabetes-specific health-related quality of life in youth with type 1 diabetes: The Global TEENs study. Diabetes Care 2017,40(8),1002-1009","journal-title":"Diabetes Care"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pcd.2019.11.003","volume":"14","author":"Al-Taie N.","year":"2020","unstructured":"Al-Taie N.; Maftei D.; Kautzky-Willer A.; Krebs M.; Stingl H.; Assessing the quality of life among patients with diabetes in Austria and the correlation between glycemic control and the quality of life. Prim Care Diabetes 2020,14(2),133-138","journal-title":"Prim Care Diabetes"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.2337\/dc20-S007","volume":"43","year":"2020","unstructured":"7. Diabetes technology: Standards of medical care in diabetes-2020. Diabetes Care American Diabetes Association2020,43(Suppl. 1),S77-S88","journal-title":"Diabetes Care"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrendo.2017.39","volume":"13","author":"Mathieu C.","year":"2017","unstructured":"Mathieu C.; Gillard P.; Benhalima K.; Insulin analogues in type 1 diabetes mellitus: Getting better all the time. Nat Rev Endocrinol 2017,13(7),385-399","journal-title":"Nat Rev Endocrinol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"CD012161","DOI":"10.1002\/14651858.CD012161","volume":"2016","author":"Fullerton B.","year":"2016","unstructured":"Fullerton B.; Siebenhofer A.; Jeitler K.; Horvath K.; Semlitsch T.; Berghold A.; Plank J.; Pieber T.R.; Gerlach F.M.; Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus. Cochrane Database Syst Rev 2016,2016(6),CD012161","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40271-017-0291-3","volume":"11","author":"Almeida P.H.R.F.","year":"2018","unstructured":"Almeida P.H.R.F.; Silva T.B.C.; de Assis Acurcio F.; Guerra J\u00fanior A.A.; Ara\u00fajo V.E.; Diniz L.M.; Godman B.; Almeida A.M.; Alvares J.; Quality of life of patients with type 1 diabetes mellitus using insulin analog glargine compared with NPH insulin: A systematic review and policy implications. Patient 2018,11(4),377-389","journal-title":"Patient"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/dia.2010.0224","volume":"13","author":"van Bon A.C.","year":"2011","unstructured":"van Bon A.C.; Bode B.W.; Sert-Langeron C.; DeVries J.H.; Charpentier G.; Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: A randomized controlled trial. Diabetes Technol Ther 2011,13(6),607-614","journal-title":"Diabetes Technol Ther"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40262-018-0696-8","volume":"58","author":"Davis A.","year":"2019","unstructured":"Davis A.; Kuriakose J.; Clements J.N.; Faster Insulin Aspart: A New Bolus Option for Diabetes Mellitus. Clin Pharmacokinet 2019,58(4),421-430","journal-title":"Clin Pharmacokinet"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.drudis.2018.11.010","volume":"24","author":"Easa N.","year":"2019","unstructured":"Easa N.; Alany R.G.; Carew M.; Vangala A.; A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade. Drug Discov Today 2019,24(2),440-451","journal-title":"Drug Discov Today"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2017.08.025","volume":"47","author":"Barski L.","year":"2018","unstructured":"Barski L.; Brandstaetter E.; Sagy I.; Jotkowitz A.; Basal insulin for the management of diabetic ketoacidosis. Eur J Intern Med 2018,47,14-16","journal-title":"Eur J Intern Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/dom.12501","volume":"17","author":"Home P.D.","year":"2015","unstructured":"Home P.D.; Plasma insulin profiles after subcutaneous injection: How close can we get to physiology in people with diabetes? Diabetes Obes Metab 2015,17(11),1011-1020","journal-title":"Diabetes Obes Metab"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.paed.2021.01.002","volume":"31","author":"Peters C.J.","year":"2021","unstructured":"Peters C.J.; Annan F.; Hindmarsh P.C.; Thompson R.J.; Insulin pump therapy. Paediatr Child Health 2021,31,129-140","journal-title":"Paediatr Child Health"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc09-S013","volume":"32","year":"2009","unstructured":"Standards of medical care in diabetes-2009. Diabetes Care American Diabetes Association2009,32(Suppl. 1),S13-S61","journal-title":"Diabetes Care"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/DMSO.S156739","volume":"11","author":"Pollock R.F.","year":"2018","unstructured":"Pollock R.F.; Chubb B.; Valentine W.J.; Heller S.; Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach. Diabetes Metab Syndr Obes 2018,11,217-226","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"CD013498","DOI":"10.1002\/14651858.CD013498.pub2","volume":"3","author":"Hemmingsen B.","year":"2021","unstructured":"Hemmingsen B.; Metzendorf M.I.; Richter B.; (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus. Cochrane Database Syst Rev 2021,3,CD013498","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","volume":"7","author":"Ceriello A.","year":"2019","unstructured":"Ceriello A.; Monnier L.; Owens D.; Glycaemic variability in diabetes: Clinical and therapeutic implications. Lancet Diabetes Endocrinol 2019,7(3),221-230","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1089\/dia.2015.0417","volume":"18","author":"Rodbard D.","year":"2016","unstructured":"Rodbard D.; Continuous glucose monitoring: A review of successes, challenges, and opportunities. Diabetes Technol Ther 2016,18(Suppl. 2),S3-S13","journal-title":"Diabetes Technol Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0140-6736(19)31142-0","volume":"394","author":"Beck R.W.","year":"2019","unstructured":"Beck R.W.; Bergenstal R.M.; Laffel L.M.; Pickup J.C.; Advances in technology for management of type 1 diabetes. Lancet 2019,394(10205),1265-1273","journal-title":"Lancet"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.lfs.2019.01.011","volume":"219","author":"Sharma A.K.","year":"2019","unstructured":"Sharma A.K.; Taneja G.; Kumar A.; Sahu M.; Sharma G.; Kumar A.; Sardana S.; Deep A.; Insulin analogs: Glimpse on contemporary facts and future prospective. Life Sci 2019,219,90-99","journal-title":"Life Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2337\/dc19-1610","volume":"43","author":"Charleer S.","year":"2020","unstructured":"Charleer S.; De Block C.; Van Huffel L.; Broos B.; Fieuws S.; Nobels F.; Mathieu C.; Gillard P.; Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): A prospective observational real- world cohort study. Diabetes Care 2020,43(2),389-397","journal-title":"Diabetes Care"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"107893","DOI":"10.1016\/j.diabres.2019.107893","volume":"157","author":"Nana M.","year":"2019","unstructured":"Nana M.; Moore S.L.; Ang E.; Lee Z.X.; Bondugulapati L.N.R.; Flash glucose monitoring: Impact on markers of glycaemic control and patient-reported outcomes in individuals with type 1 diabetes mellitus in the real-world setting. Diabetes Res Clin Pract 2019,157,107893","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.dsx.2019.07.054","volume":"13","author":"Pintus D.","year":"2019","unstructured":"Pintus D.; Ng S.M.; Freestyle libre flash glucose monitoring improves patient quality of life measures in children with Type 1 Diabetes Mellitus (T1DM) with appropriate provision of education and support by healthcare professionals. Diabetes Metab Syndr 2019,13(5),2923-2926","journal-title":"Diabetes Metab Syndr"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2337\/dc17-0133","volume":"40","author":"Polonsky W.H.","year":"2017","unstructured":"Polonsky W.H.; Hessler D.; Ruedy K.J.; Beck R.W.; The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: Further findings from the DIAMOND randomized clinical trial. Diabetes Care 2017,40(6),736-741","journal-title":"Diabetes Care"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/dia.2017.0363","volume":"20","author":"&#xD3;lafsd\u00f3ttir A.F.","year":"2018","unstructured":"&#xD3;lafsd\u00f3ttir A.F.; Polonsky W.; Bolinder J.; Hirsch I.B.; Dahlqvist S.; Wedel H.; Nystr\u00f6m T.; Wijkman M.; Schwarcz E.; Hellman J.; Heise T.; Lind M.; A randomized clinical trial of the effect of continuous glucose monitoring on nocturnal hypoglycemia, daytime hypoglycemia, glycemic variability, and hypoglycemia confidence in persons with type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technol Ther 2018,20(4),274-284","journal-title":"Diabetes Technol Ther"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1464-5491.2010.03177.x","volume":"28","author":"Hoeks L.B.","year":"2011","unstructured":"Hoeks L.B.; Greven W.L.; de Valk H.W.; Real-time continuous glucose monitoring system for treatment of diabetes: A systematic review. Diabet Med 2011,28(4),386-394","journal-title":"Diabet Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"CD008101","DOI":"10.1002\/14651858.CD008101.pub2","volume":"1","author":"Langendam M.","year":"2012","unstructured":"Langendam M.; Luijf Y.M.; Hooft L.; Devries J.H.; Mudde A.H.; Scholten R.J.; Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev 2012,1,CD008101","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e039400","DOI":"10.1136\/bmjopen-2020-039400","volume":"10","author":"Zhou Y.","year":"2020","unstructured":"Zhou Y.; Deng H.; Liu H.; Yang D.; Xu W.; Yao B.; Yan J.; Weng J.; Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: Protocol of a multicentre randomised controlled trial. BMJ Open 2020,10(12),e039400","journal-title":"BMJ Open"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"d3805","DOI":"10.1136\/bmj.d3805","volume":"343","author":"Pickup J.C.","year":"2011","unstructured":"Pickup J.C.; Freeman S.C.; Sutton A.J.; Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Meta-analysis of randomised controlled trials using individual patient data. BMJ 2011,343,d3805","journal-title":"BMJ"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"108502","DOI":"10.1016\/j.diabres.2020.108502","volume":"170","author":"Galindo R.J.","year":"2020","unstructured":"Galindo R.J.; Aleppo G.; Continuous glucose monitoring: The achievement of 100\u00a0years of innovation in diabetes technology. Diabetes Res Clin Pract 2020,170,108502","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pcd.2020.10.013","volume":"15","author":"Edelman S.V.","year":"2021","unstructured":"Edelman S.V.; Cavaiola T.S.; Boeder S.; Pettus J.; Utilizing continuous glucose monitoring in primary care practice: What the numbers mean. Prim Care Diabetes 2021,15(2),199-207","journal-title":"Prim Care Diabetes"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/2230-8210.183472","volume":"20","author":"Ghazanfar H.","year":"2016","unstructured":"Ghazanfar H.; Rizvi S.W.; Khurram A.; Orooj F.; Qaiser I.; Impact of insulin pump on quality of life of diabetic patients. Indian J Endocrinol Metab 2016,20(4),506-511","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/MJT.0000000000001097","volume":"27","author":"Nimri R.","year":"2020","unstructured":"Nimri R.; Nir J.; Phillip M.; Insulin pump therapy. Am J Ther 2020,27(1),e30-e41","journal-title":"Am J Ther"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"CD005103","DOI":"10.1002\/14651858.CD005103.pub2","author":"Misso M.L.","year":"2010","unstructured":"Misso M.L.; Egberts K.J.; Page M.; O\u2019Connor D.; Shaw J.; Continuous Subcutaneous Insulin Infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010(1),CD005103","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000503705","volume":"29","author":"Mesbah N.I.","year":"2020","unstructured":"Mesbah N.I.; Taha N.A.; Rahme Z.N.; Sukkar F.F.; Omar D.M.; Experiences of adults using continuous subcutaneous insulin infusion: A qualitative study. Med Princ Pract 2020,29(3),255-261","journal-title":"Med Princ Pract"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/jan.13463","volume":"74","author":"Payk M.","year":"2018","unstructured":"Payk M.; Robinson T.; Davis D.; Atchan M.; An integrative review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes. J Adv Nurs 2018,74(3),528-538","journal-title":"J Adv Nurs"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.diabet.2010.01.004","volume":"36","author":"Riveline J.P.","year":"2010","unstructured":"Riveline J.P.; Franc S.; Biedzinski M.; Jollois F.X.; Messaoudi N.; Lagarde F.; Lormeau B.; Pichard S.; Varroud-Vial M.; Deburge A.; Dresco E.; Charpentier G.; Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapy. Diabetes Metab 2010,36(3),229-233","journal-title":"Diabetes Metab"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.diabres.2010.04.010","volume":"89","author":"Wu Y.P.","year":"2010","unstructured":"Wu Y.P.; Graves M.M.; Roberts M.C.; Mitchell A.C.; Is insulin pump therapy better than injection for adolescents with diabetes? Diabetes Res Clin Pract 2010,89(2),121-125","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1517\/17425247.2016.1115013","volume":"13","author":"Thabit H.","year":"2016","unstructured":"Thabit H.; Hovorka R.; Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: A comparative overview and future horizons. Expert Opin Drug Deliv 2016,13(3),389-400","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40272-014-0064-6","volume":"16","author":"Malik F.S.","year":"2014","unstructured":"Malik F.S.; Taplin C.E.; Insulin therapy in children and adolescents with type 1 diabetes. Paediatr Drugs 2014,16(2),141-150","journal-title":"Paediatr Drugs"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pedn.2020.08.007","volume":"55","author":"Lipman T.H.","year":"2020","unstructured":"Lipman T.H.; Willi S.M.; Lai C.W.; Smith J.A.; Patil O.; Hawkes C.P.; Insulin pump use in children with type 1 diabetes: Over a decade of disparities. J Pediatr Nurs 2020,55,110-115","journal-title":"J Pediatr Nurs"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/pedi.12121","volume":"15","author":"Blackman S.M.","year":"2014","unstructured":"Blackman S.M.; Raghinaru D.; Adi S.; Simmons J.H.; Ebner-Lyon L.; Chase H.P.; Tamborlane W.V.; Schatz D.A.; Block J.M.; Litton J.C.; Raman V.; Foster N.C.; Kollman C.R.; DuBose S.N.; Miller K.M.; Beck R.W.; DiMeglio L.A.; Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes 2014,15(8),564-572","journal-title":"Pediatr Diabetes"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/dia.2011.0162","volume":"14","author":"Rubin R.R.","year":"2012","unstructured":"Rubin R.R.; Peyrot M.; Health-related quality of life and treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial. Diabetes Technol Ther 2012,14(2),143-151","journal-title":"Diabetes Technol Ther"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00592-013-0466-x","volume":"51","author":"Cherubini V.","year":"2014","unstructured":"Cherubini V.; Gesuita R.; Bonfanti R.; Franzese A.; Frongia A.P.; Iafusco D.; Iannilli A.; Lombardo F.; Rabbone I.; Sabbion A.; Salvatoni A.; Scaramuzza A.; Schiaffini R.; Sulli N.; Toni S.; Tumini S.; Mosca A.; Carle F.; Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study. Acta Diabetol 2014,51(1),43-51","journal-title":"Acta Diabetol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1017\/S0266462312000797","volume":"29","author":"Luk\u00e1cs A.","year":"2013","unstructured":"Luk\u00e1cs A.; Kiss-T\u00f3th E.; Varga B.; So\u00f3s A.; Tak\u00e1c P.; Barkai L.; Benefits of continuous subcutaneous insulin infusion on quality of life. Int J Technol Assess Health Care 2013,29(1),48-52","journal-title":"Int J Technol Assess Health Care"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2050312117694938","DOI":"10.1177\/2050312117694938","volume":"5","author":"Hussain T.","year":"2017","unstructured":"Hussain T.; Akle M.; Nagelkerke N.; Deeb A.; Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy. SAGE Open Med 2017,5,2050312117694938","journal-title":"SAGE Open Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.diabres.2014.09.028","volume":"106","author":"Birkebaek N.H.","year":"2014","unstructured":"Birkebaek N.H.; Kristensen L.J.; Mose A.H.; Thastum M.; Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Res Clin Pract 2014,106(3),474-480","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e020274","DOI":"10.1136\/bmjopen-2017-020274","volume":"8","author":"McAuley S.A.","year":"2018","unstructured":"McAuley S.A.; de Bock M.I.; Sundararajan V.; Lee M.H.; Paldus B.; Ambler G.R.; Bach L.A.; Burt M.G.; Cameron F.J.; Clarke P.M.; Cohen N.D.; Colman P.G.; Davis E.A.; Fairchild J.M.; Hendrieckx C.; Holmes-Walker D.J.; Horsburgh J.C.; Jenkins A.J.; Kaye J.; Keech A.C.; King B.R.; Kumareswaran K.; MacIsaac R.J.; McCallum R.W.; Nicholas J.A.; Sims C.; Speight J.; Stranks S.N.; Trawley S.; Ward G.M.; Vogrin S.; Jones T.W.; O\u2019Neal D.N.; Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: A randomised controlled trial protocol. BMJ Open 2018,8(6),e020274","journal-title":"BMJ Open"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/dme.13816","volume":"36","author":"Boughton C.K.","year":"2019","unstructured":"Boughton C.K.; Hovorka R.; Is an artificial pancreas (closed-loop system) for type 1 diabetes effective? Diabet Med 2019,36(3),279-286","journal-title":"Diabet Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4158\/EP-2018-0515","volume":"25","author":"Faulds E.R.","year":"2019","unstructured":"Faulds E.R.; Zappe J.; Dungan K.M.; Real-world implications of Hybrid Close Loop (HCL) insulin delivery system. Endocr Pract 2019,25(5),477-484","journal-title":"Endocr Pract"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","volume":"392","author":"Tauschmann M.","year":"2018","unstructured":"Tauschmann M.; Thabit H.; Bally L.; Allen J.M.; Hartnell S.; Wilinska M.E.; Ruan Y.; Sibayan J.; Kollman C.; Cheng P.; Beck R.W.; Acerini C.L.; Evans M.L.; Dunger D.B.; Elleri D.; Campbell F.; Bergenstal R.M.; Criego A.; Shah V.N.; Leelarathna L.; Hovorka R.; Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: A multicentre, 12-week randomised trial. Lancet 2018,392(10155),1321-1329","journal-title":"Lancet"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.beem.2015.03.001","volume":"29","author":"Battelino T.","year":"2015","unstructured":"Battelino T.; Omladi\u010d J.\u0160.; Phillip M.; Closed loop insulin delivery in diabetes. Best Pract Res Clin Endocrinol Metab 2015,29(3),315-325","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e0212013","DOI":"10.1371\/journal.pone.0212013","volume":"14","author":"Schierloh U.","year":"2019","unstructured":"Schierloh U.; Wilinska M.E.; Pit-Ten Cate I.M.; Baumann P.; Hovorka R.; De Beaufort C.; Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial. PLoS One 2019,14(3),e0212013","journal-title":"PLoS One"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2042018820950146","DOI":"10.1177\/2042018820950146","volume":"11","author":"Wu Z.","year":"2020","unstructured":"Wu Z.; Luo S.; Zheng X.; Bi Y.; Xu W.; Yan J.; Yang D.; Weng J.; Use of a do-it-yourself artificial pancreas system is associated with better glucose management and higher quality of life among adults with type 1 diabetes. Ther Adv Endocrinol Metab 2020,11,2042018820950146","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clnesp.2020.12.018","volume":"42","author":"Marques R.M.B.","year":"2021","unstructured":"Marques R.M.B.; Rodrigues M.L.M.; Marini A.C.B.; Santos C.R.D.C.; Schincaglia R.M.; Associated factors with the quality of life of adolescents with type 1 diabetes. Clin Nutr ESPEN 2021,42,387-392","journal-title":"Clin Nutr ESPEN"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"9075","DOI":"10.1007\/s12035-018-1044-6","volume":"55","author":"Rehni A.K.","year":"2018","unstructured":"Rehni A.K.; Dave K.R.; Impact of hypoglycemia on brain metabolism during diabetes. Mol Neurobiol 2018,55(12),9075-9088","journal-title":"Mol Neurobiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.diabres.2016.10.018","volume":"126","author":"Fisher L.","year":"2017","unstructured":"Fisher L.; Tang T.; Polonsky W.; Assessing quality of life in diabetes: I. A practical guide to selecting the best instruments and using them wisely. Diabetes Res Clin Pract 2017,126,278-285","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S2213-8587(17)30001-3","volume":"5","author":"Bally L.","year":"2017","unstructured":"Bally L.; Thabit H.; Kojzar H.; Mader J.K.; Qerimi-Hyseni J.; Hartnell S.; Tauschmann M.; Allen J.M.; Wilinska M.E.; Pieber T.R.; Evans M.L.; Hovorka R.; Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: An open-label, randomised, crossover study. Lancet Diabetes Endocrinol 2017,5(4),261-270","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/pedi.12487","volume":"18","author":"Stahl-Pehe A.","year":"2017","unstructured":"Stahl-Pehe A.; Landwehr S.; Lange K.S.; B\u00e4chle C.; Castillo K.; Yossa R.; L\u00fcdtke J.; Holl R.W.; Rosenbauer J.; Impact of quality of life (QoL) on glycemic control (HbA1c) among adolescents and emerging adults with long-duration type 1 diabetes: A prospective cohort-study. Pediatr Diabetes 2017,18(8),808-816","journal-title":"Pediatr Diabetes"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.arcped.2019.11.002","volume":"27","author":"Khemakhem R.","year":"2020","unstructured":"Khemakhem R.; Dridi Y.; Hamza M.; Ben Hamouda A.; Khlayfia Z.; Ouerda H.; Halioui S.; Siala N.; Belhadj A.; Maherzi A.; Living with type 1 diabetes mellitus: How does the condition affect children\u2019s and adolescents\u2019 quality of life? Arch Pediatr 2020,27(1),24-28","journal-title":"Arch Pediatr"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s13300-020-00859-1","volume":"11","author":"Ueno K.","year":"2020","unstructured":"Ueno K.; Chujo D.; Takahashi N.; Ohsugi M.; Ueki K.; Kajio H.; Patient satisfaction and clinical efficacy of flash glucose monitoring in patients with type 1 diabetes: A prospective, single-center, single-arm study. Diabetes Ther 2020,11(8),1883-1890","journal-title":"Diabetes Ther"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399818666211103163208","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197657\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399818666211103163208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:50:20Z","timestamp":1671274220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197657\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399818666211103163208","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e031121197657"}}